In vitro human T cell sensitization to haptens by monocyte-derived dendritic cells

Area of Science:

• Immunology
• Dermatology
• Toxicology

Background:

• Previous in vitro methods using Langerhans cells (LC) to identify contact sensitizers were limited by human skin sample availability.
• Developing alternative in vitro assays is crucial for reducing animal experimentation in toxicology.

Purpose of the Study:

• To evaluate the use of monocyte-derived dendritic cells (DC) for in vitro assessment of T cell response to allergens and irritants.
• To establish a reliable method for discriminating between strong contact sensitizers and irritants.

Main Methods:

• Human monocytes were isolated and differentiated into mature dendritic cells (DC) using granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-4 (IL-4), and tumor necrosis factor-alpha (TNF-alpha).
• Mature DC were treated with various haptens (trinitrophenyl (TNP), fluorescein isothiocyanate (FITC)), prohaptens (eugenol, isoeugenol), and an irritant (sodium lauryl sulfate (SLS)).
• Autologous T cell proliferation was measured in response to treated DC to assess sensitization potential.

Main Results:

• Mature DC treated with TNP induced significant T cell proliferation in all tested cases.
• FITC induced positive T cell proliferation in approximately 50% of experiments.
• Eugenol and isoeugenol showed variable proliferation responses, while SLS-treated DC did not induce T cell proliferation.
• The in vitro model successfully differentiated between strong contact sensitizers and irritants.

Conclusions:

• Monocyte-derived dendritic cells (DC) provide a viable alternative to Langerhans cells (LC) for in vitro assessment of skin sensitization.
• This DC-based assay effectively distinguishes strong contact sensitizers from irritants.
• The developed in vitro model holds significant potential for reducing animal testing in the evaluation of chemical sensitizers.